Betahistine-Associated Weight Loss and Improved Cognitive and Negative Symptoms: Domain in Early-Onset Schizophrenia-Reference-Cited by-同舟云学术

Betahistine-Associated Weight Loss and Improved Cognitive and Negative Symptoms: Domain in Early-Onset Schizophrenia

Published:2019-11 Issue:6 Volume:26 Page:e790-e792
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Naguy Ahmed,AlShalabi Sara R.,AlKhadhari Sulaiman

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference8 articles.

1. Add-on gabapentin alleviates paliperidone-induced head tremors and boosts antipsychotic response in early-onset schizophrenia;Naguy;Isr J Psychiatry Relat Sci.,2017

2. Metformin for antipsychotic-related metabolic syndrome in children: fact or fiction?;Naguy;Chin Med J (Engl).,2018

3. Ameliorating antipsychotic-induced weight gain by betahistine: mechanisms and clinical implications;Lian;Pharmacol Res.,2016

4. Betahistine decreases olanzapine-induced weight gain and somnolence in humans;Barak;J Psychopharmacol (Oxford),2016

5. A randomized, double-blind, placebo-controlled pilot study of betahistine to counteract olanzapine-associated weight gain;Barak;J Clin Psychopharmacol.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of serum interleukin-6 with negative symptoms in stable early-onset schizophrenia;World Journal of Psychiatry;2024-06-19

2. Association of serum IL-6 with negative symptoms in stable early-onset schizophrenia;2024-03-04

3. Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia;International Journal of Molecular Sciences;2023-05-23

4. Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study;Neuropsychiatric Disease and Treatment;2023-02

5. Adjuvant Pitolisant in a Case With Early-Onset Schizophrenia;Clinical Neuropharmacology;2021-08-27